Douglas White, CEO, OpGen, Inc.
Doug joined OpGen as Chief Executive Officer in June of 2010. Doug brings 25 years of experience in the in vitro diagnostics market serving in multiple senior executive roles. His roles have included the leadership and development of commercial organizations and partnerships at BG Medicine, QIAGEN, Digene, Bayer, and Chiron Diagnostics. Doug’s extensive experience in the Molecular Diagnostics market played an integral role in the development of high value, clinically relevant, technologies, systems and assays throughout his career.
Prior to joining OpGen, Doug served as Executive Vice President and General Manager for BG Medicine, a life science company focused on the development and commercialization of novel diagnostics tests. Prior to BG Medicine Doug was Senior Vice President of Sales and Marketing, Americas, and Chair of the Americas Management Counsel at QIAGEN. At Digene he served as the Senior Vice President of Commercial Operations, where he was responsible for all commercial activities in the Americas and Asia Pacific in addition to the global product management organization. In addition, Doug held several executive positions in the diagnostic industry, including Vice President of U.S. Sales and Marketing, Vice President of Global Product Management, Nucleic Acid Diagnostics, at Bayer Diagnostics, Vice President, Marketing, for Chiron Diagnostics as well as different management roles in sales, market development, strategic and tactical marketing through his career at Chiron and Abbott Diagnostics.
Doug received his BA in Political Science from Washington College.
Eric Winzer, Chief Financial Officer
Eric joined OpGen as Chief Financial Officer in June 2009. Eric brings almost 30 years of experience in addressing diverse financial issues including raising capital, financial reporting, investor relations, banking, taxation, mergers and acquisitions, financial planning and analysis, and accounting operations. Eric is responsible for all financial functions at the Company.
Prior to joining Opgen, Eric served as Executive Vice President and Chief Financial Officer for Avalon Pharmaceuticals, Inc., a biotechnology company developing targeted therapeutics for oncology. Prior to Avalon, Eric was with Life Technologies Corporation (formerly Invitrogen Corporation), a provider of life science technologies for disease research and drug discovery, where he served as Senior VP and Chief Financial Officer, Executive Sponsor for Life’s ERP implementation, and as the VP of Finance. Previously held positions also include Eric’s tenure at Life Technologies Incorporated, where he assumed increasing responsibility as Chief Financial Officer, Secretary and Treasurer, and additionally held various financial positions at Genex Corporation. Currently, Eric serves as director and audit committee chair at Cytomedix, Inc.
Eric received his B.A. in Economics and Business Administration from McDaniel College and an M.B.A. from Mount Saint Mary’s University.
John Henkhaus, Vice President, Diagnostic Content
John is a founding member of OpGen, joining the company in February 2002. He brings over 15 years of technical management experience, with particular focus in genomics technologies, bioinformatics and microbiology. John and his team are responsible for driving the information engine at OpGen, integrating Optical Mapping and other genomics technologies towards developing and expanding the diagnostic database.
Prior to joining OpGen, John served as Senior Production Manager for Incyte, a pioneer in the emerging genomics industry, where he managed five departments providing genomic services and bioreagents to the broader life science industry. Prior to Incyte, John supervised research teams engaged in multiple sequencing projects including the Human Genome Project at Washington University.
BS Microbiology, Southern Illinois University, 1993
Mike Fitzpatrick, Vice President, Sales and Commercial Development
Mike joined OpGen as Vice President of Sales and Commercial Development in August 2008. Mike brings over 25 years of experience in sales and executive sales management. He has built and managed global sales and support teams. At OpGen he is responsible for refining the go-to-market strategy, establishing commercial processes and deploying field based distribution channels for sales and support.
Prior to joining OpGen, Mike has held numerous executive sales positions most recently at Codon Devices where he built the initial global field team. Prior to Codon, Mike spent 20 years with Applied Biosystems where he was Vice President of Global Key Accounts, Vice President of Sales for the Molecular Biology Division and Vice President of the Americas. He has been responsible for revenues exceeding $1 billion across a global customer base in the areas of academic research, pharmaceutical and biotechnology and applied markets.
Mike has a degree in Microbiology from the University of Maryland, College Park and extensive course work in sales management programs.
Ed Andrews, Vice President, Product Development
Ed joined OpGen as Vice President of Product Development in May of 2006 and brings to Opgen extensive experience in new product design, development, manufacturing and business leadership. At OpGen, he leads a talented team of engineers and scientists working on instrumentation and lab-on-card based systems.
Prior to joining OpGen, Ed was a Plant Manager for Sanmina-SCI Corporation, a world-wide provider of out-sourced contract manufacturing services. Prior to this, Ed was an Executive Vice President at GDXI, an ECG services business. Here he led the development of FDA approved, CE certified, ECG telediagnostic instruments. Before co-founding GDXI, Ed spent seventeen years with GE Healthcare in a number of product design and management roles across a spectrum of medical devices including patient monitoring products, Cardiac, Fluoroscopic, and Digital Subtraction Angiographic X-ray systems, CT Scanners, and Ultrasound systems. While at GE, he was granted six patents for his medical product innovations.
Ed holds a BS degree in Electrical/Computer Science from the University of Wisconsin — Milwaukee and has participated in numerous business and management training programs.
Larry Wellman, Vice President, Human Resources
Larry joined OpGen as Vice President, Human Resources in July 2008. Larry is responsible for talent acquisition, retention, rewards, performance management and development strategies. Larry brings to the company extensive experience leading organizations through rapid and significant growth both domestically and internationally. His commitment to talent development ensures the continual improvement and growth of both the individual and the organization.
Prior to joining OpGen, Larry served as Vice President, Human Resources for Digene Corporation (now Qiagen), a medical diagnostics firm that develops, manufactures and markets proprietary DNA and RNA tests for the detection, screening and monitoring of human diseases. During his tenure, the company grew from $17 million to over $200 million in revenue, significantly increasing the manpower demands to support that intense growth. Prior to Digene, Larry was Director, Human Resources for two established companies that opened new operations in the mid-west, Bear Creek Corporation, and prior to Bear Creek, Atlas Editions. Larry’s breadth of “people” experience is assembled from diverse industries including, biotechnology, high-tech, service-based and manufacturing environments, each contributing to his solid understanding of employee relations, resource planning and human capital management.
Larry holds an MBA in Finance and a BS in Human Resources, both from Indiana University.
Richard Moore, MD, PhD, Vice President, Diagnostic Systems
Rich joined OpGen as the Vice President of Diagnostic Systems in October 2008. Rich brings to the company significant experience in product development and molecular infectious disease diagnostics. Rich currently leads Systems Integration and Assay Development efforts for infectious disease products.
Prior to joining OpGen, Rich served as the Director of Research, Technology Development, and Systems Integration for the Diagnostic Systems unit of Becton Dickinson (BD). At BD, Rich was involved in the development of several instrumented diagnostic systems in including ProbeTec ET and Viper. Prior to BD, Rich worked in the point of care diagnostics group at IGEN, now BioVeris.
Rich obtained an MD and a PhD in Cellular Immunology from University of Maryland at Baltimore and a BS in Chemical and Nuclear Engineering from University of Maryland, College Park.
